What is the half-life of hydroxyzine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Hydroxyzine

The elimination half-life of hydroxyzine is approximately 20 hours in healthy adults, though this can be significantly prolonged to 36.6 hours in patients with hepatic dysfunction such as primary biliary cirrhosis. 1, 2

Pharmacokinetic Parameters in Different Populations

Healthy Adults

  • Elimination half-life: approximately 20 hours 1
  • Total body clearance: 5-12 mL/min/kg 1
  • Apparent volume of distribution: exceeds 4 L/kg, with some studies showing values as high as 22.7 L/kg 1, 2
  • Peak plasma concentrations occur at 2-3 hours after oral administration 1

Pediatric Patients

  • Children have shorter elimination half-lives compared to adults, though specific values vary 1, 3
  • The guideline for brain death determination in children lists hydroxyzine with a half-life range in infants/children, acknowledging age-dependent variability 4

Patients with Hepatic Impairment

  • In patients with primary biliary cirrhosis, the mean elimination half-life extends to 36.6 ± 13.1 hours (nearly double that of healthy adults) 2
  • Clearance is reduced to 8.65 ± 7.46 mL/min/kg in these patients 2
  • Volume of distribution increases to 22.7 ± 13.3 L/kg 2

Patients with Renal Impairment

  • Dose reduction by half is recommended in patients with moderate to severe renal impairment 4
  • Hydroxyzine should be avoided in severe renal impairment (creatinine clearance < 10 mL/min) 4

Clinical Implications

Dosing Frequency

  • The relatively long half-life of approximately 20 hours suggests hydroxyzine can be administered once daily in adults, though traditional dosing is often divided (e.g., 25 mg four times daily for urticaria) 4, 1
  • When used as a nighttime sedating antihistamine, typical doses range from 10-50 mg 4

Time to Steady State and Washout

  • Complete elimination requires 5-7 half-lives, meaning hydroxyzine may remain in the body for approximately 4-7 days in healthy adults (100-140 hours) 1
  • In patients with hepatic dysfunction, this extends to 7-10 days or longer 2
  • Steady-state concentrations are reached after several days of regular dosing 3

Active Metabolite Considerations

  • Cetirizine is the active metabolite of hydroxyzine with its own pharmacologic activity 4, 2
  • In patients with primary biliary cirrhosis, cetirizine has a mean elimination half-life of 25.0 ± 8.2 hours 2
  • Peak cetirizine levels occur at approximately 4.8 hours after hydroxyzine administration 2

Important Clinical Caveats

Sedation and CNS Effects

  • Hydroxyzine causes sedation in approximately 80% of patients, the highest rate among first-generation antihistamines 4
  • All patients in the hepatic dysfunction study became sleepy for 0.5-6 hours after dosing 2
  • The prolonged half-life means sedative effects can persist well beyond the initial dosing period 1

Drug Testing Considerations

  • Antihistamine suppression of skin testing can persist for extended periods due to the long half-life 2
  • In patients with hepatic dysfunction, wheal suppression lasted 1-120 hours and flare suppression lasted 1-144 hours after a single dose 2

Special Populations Requiring Caution

  • Older adults are at high risk for anticholinergic side effects including prostatic hypertrophy complications, elevated intraocular pressure, and cognitive impairment 4
  • The long half-life increases accumulation risk with repeated dosing, particularly in elderly patients 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.